Please check your internet connection and try again.
# Dicyclomine hydrochloride
## Overview
Dicyclomine is an antispasmodic and anticholinergic agent that acts by direct relaxation of smooth muscle in the gastrointestinal tract and by blocking acetylcholine at parasympathetic sites.
## Primary Indications
- Treatment of functional bowel/irritable bowel syndrome (IBS).
## Adult Dosing
- **Oral:** 20 mg four times daily.
- **Maintenance:** If efficacy is observed, may increase to 40 mg four times daily after one week.
- **Max dose:** 160 mg/day (40 mg QID). Discontinue if efficacy is not achieved within 2 weeks.
- **Intramuscular (IM):** 20 mg every 4 to 6 hours. (Note: IM route is for short-term use only; not for IV use).
## Pediatric Dosing
- **Safety and efficacy have not been established** for pediatric patients. Use is generally avoided in infants due to reports of serious respiratory and CNS effects.
## Dose Adjustments
- **Geriatric:** Start at the lowest possible dose (10 mg). Caution is advised due to increased risk of anticholinergic side effects (e.g., confusion, urinary retention, falls).
- **Renal/Hepatic Impairment:** No specific guidelines; use with caution.
## Contraindications
- Hypersensitivity to dicyclomine.
- Infants < 6 months old.
- Unstable cardiovascular status in acute hemorrhage.
- Myasthenia gravis.
- Obstructive GI disease (e.g., paralytic ileus, pyloroduodenal obstruction).
- Severe ulcerative colitis or toxic megacolon.
- Glaucoma.
- Prostatic hypertrophy/urinary obstructive uropathy.
## Adverse Effects
- **Common:** Xerostomia (dry mouth), dizziness, blurred vision, nausea, nervousness, somnolence, and constipation.
- **Serious:** Tachycardia, palpitations, urinary retention, heatstroke (due to decreased sweating), and psychosis/confusion (especially in the elderly).
## Key Drug Interactions
- **Anticholinergics:** Additive effects (e.g., antihistamines, tricyclic antidepressants, antipsychotics).
- **Potassium Chloride:** Increased risk of GI mucosal ulceration from solid dosage forms due to delayed transit time.
- **Digoxin:** Increased serum concentrations due to decreased GI motility.
## Monitoring
- Monitor for improvement in IBS symptoms.
- Assess for anticholinergic toxicity (tachycardia, confusion, urinary output).
- Monitor for signs of heat exhaustion in hot, humid environments.
## Clinical Pearls
- Administer dose 30 minutes before meals.
- Taper gradually if used for prolonged periods to avoid withdrawal-like symptoms.
- Significantly higher anticholinergic burden compared to other antispasmodics; consider safer alternatives (e.g., peppermint oil or antidiarrheals) in the elderly.
- Dicyclomine should not be used to treat patients with undiagnosed abdominal pain or patients with pre-existing autonomic neuropathy.
***
**Educational Disclaimer:** This information is for educational purposes only. Clinical practice protocols vary by institution. Always verify dosages, contraindications, and drug interactions against the most current FDA-labeled prescribing information (e.g., DailyMed) or institutional clinical decision support tools before prescribing or administering medication.